Ana Lucrecia Woodward

Array ( [id] => 8685113 [patent_doc_number] => 20130053398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'MODULATORS OF FATTY ACID AMIDE HYDROLASE' [patent_app_type] => utility [patent_app_number] => 13/695855 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11945 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574118 [patent_doc_number] => 20110269774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK' [patent_app_type] => utility [patent_app_number] => 13/097271 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38898 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269774.pdf [firstpage_image] =>[orig_patent_app_number] => 13097271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515417 [patent_doc_number] => 08039489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Guanidine-containing compounds useful as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/096651 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26657 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039489.pdf [firstpage_image] =>[orig_patent_app_number] => 13096651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153831 [patent_doc_number] => 08586737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Process of a quaternary ammonium salt using phosphate' [patent_app_type] => utility [patent_app_number] => 13/093985 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8607 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13093985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034910 [patent_doc_number] => 20130237548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'INJECTABLE EMULSION OF SEDATIVE HYPNOTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/695140 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3479 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9643241 [patent_doc_number] => 20140221354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 14/007613 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44385 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676960 [patent_doc_number] => 08815869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Lactam acetamides as calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 13/045010 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24869 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909482 [patent_doc_number] => 08481546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'CGRP receptor antagonist' [patent_app_type] => utility [patent_app_number] => 13/038550 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12569 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13038550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244937 [patent_doc_number] => 08202864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 13/035366 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8244 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202864.pdf [firstpage_image] =>[orig_patent_app_number] => 13035366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214461 [patent_doc_number] => 08193191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Urotensin II receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/026549 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100052 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193191.pdf [firstpage_image] =>[orig_patent_app_number] => 13026549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483836 [patent_doc_number] => 20120283242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS' [patent_app_type] => utility [patent_app_number] => 13/318053 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 164637 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026045 [patent_doc_number] => 09067932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Pyrazolopyridine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/014505 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28380 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13014505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003192 [patent_doc_number] => 20110118280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/012321 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15024 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118280.pdf [firstpage_image] =>[orig_patent_app_number] => 13012321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510352 [patent_doc_number] => 20120309760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'PIPERAZINE COMPOUND HAVING A PGDS INHIBITORY EFFECT' [patent_app_type] => utility [patent_app_number] => 13/522605 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21863 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003185 [patent_doc_number] => 20110118279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/007194 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99740 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118279.pdf [firstpage_image] =>[orig_patent_app_number] => 13007194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9923120 [patent_doc_number] => 08981084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Oxadiazole HDAC inhibitors' [patent_app_type] => utility [patent_app_number] => 13/522070 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43418 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618230 [patent_doc_number] => 20130023541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'VOLTAGE-GATED SODIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 13/522183 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83248 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232844 [patent_doc_number] => 08198283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Cysteine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/986830 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22598 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198283.pdf [firstpage_image] =>[orig_patent_app_number] => 12986830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9850276 [patent_doc_number] => 08952004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-10 [patent_title] => 'CXCR3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/520234 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37026 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638175 [patent_doc_number] => 20130029978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'NOVEL ARYL UREA DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/261340 [patent_app_country] => US [patent_app_date] => 2010-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41985 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261340 [rel_patent_id] =>[rel_patent_doc_number] =>)